UNSPSC 51285405: Cefrotil

This classification denotes a cephalosporin antibiotic with the molecular formula C20H22N4O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 44P98H0A27, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-methyl-8-oxo-7-(((4-(1,4,5,6-tetrahydro-2-pyrimidinyl)phenyl)acetyl)amino)-, (6r,7r)- but more generally known as cefrotil, which bears US NIH Compound Identifier 68692.

UNSPSC 51285405 Cefrotil (Commodity) does not align with the recent state and local procurement activity tagged to this code. The two most recent opportunities on file are a completed pharmaceutical warehouse piggyback contract awarded by the Illinois Department of Public Health for broad-spectrum antibiotics (Doxycycline Hyclate and Ciprofloxacin Hydrochloride), and a Seminole County, Florida competitive bid for Naloxone and drug deactivation systems. Neither involves Cefrotil, a third-generation cephalosporin antibiotic. The code shows little relevant recent activity in state and local procurement under its nominal scope.

The Illinois Department of Public Health awarded a $2,999,999.11 contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 (completed award, not an open solicitation) for pharmaceutical warehouse supply via an Invitation for Bid process. Seminole County, Florida posted an IFB on June 30, 2026 with response deadline of July 26, 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries required and FEMA potential funding. The mismatch between the code's name and the actual procurement activity suggests either a tagging error in the state and local procurement database or limited contemporary demand for Cefrotil in state and local health procurement channels.